Physician profile
Daniel Alves
NPI 1518018746
$1,572.03
in general payments reported to CMS, 2019-2025
18 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $70.16 · 2021: $46.95 · 2022: $268 · 2023: $318 · 2024: $210 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615 · Education: $35.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.37 |
| Education | $35.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $548.26 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Pfizer INC. | $140.57 | 2019 | |
| Abbott Laboratories | $136.81 | 2020-2023 | Proclaim |
| Si-Bone, INC. | $123.52 | 2019 | |
| Abbvie INC. | $110.19 | 2024-2025 | |
| Biotronik INC. | $96.34 | 2022 | |
| Medtronic, INC. | $87.28 | 2021-2024 | Mazor X System, Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $71.54 | 2022-2023 | Xtampza |
| Medtronic USA, INC. | $46.02 | 2019 | |
| Curonix LLC | $35.32 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $30.30 | 2019 | |
| Scilex Pharmaceuticals INC. | $24.02 | 2019 | |
| Nalu Medical, INC. | $23.58 | 2023 | Nalu Neurostimulation System |
| Fidia Pharma USA INC. | $23.35 | 2019 | |
| Forte Bio-Pharma LLC | $21.87 | 2025 | Prolate, Tanlor, Nalocet |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $20.31 | 2024 | Mild Device Kit |
| Cadwell Industries, INC | $17.91 | 2023 | |
| Glaxosmithkline, LLC. | $14.84 | 2024 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Alves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.